MITF and melanoma: Accordingly, a time and dose-dependent selection of melanoma cells in the presence of a BRAFi, resulted in the early phases of selection at low doses of drug exposure in strong upregulation of the levels of both miR-579-3p and MITF together with markers of differentiation.